You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jan 10, 2026

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
Published on: October 20, 2016
Ella Borberg1,2,3, Zoe Swank1,2,3, Tal Gilboa1,2,3
1Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, United States.
Researchers developed a digital Seed Amplification Assay (dSAA) to precisely quantify TDP-43 seeds in cerebrospinal fluid (CSF). This sensitive diagnostic tool shows potential for identifying frontotemporal dementia with TDP-43 pathology (FTLD-TDP) and related diseases.
11:03Use of Capillary Electrophoresis Immunoassay to Search for Potential Biomarkers of Amyotrophic Lateral Sclerosis in Human Platelets
Published on: February 10, 2020
13:31Novel Atomic Force Microscopy Based Biopanning for Isolation of Morphology Specific Reagents against TDP-43 Variants in Amyotrophic Lateral Sclerosis
Published on: February 12, 2015
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: